These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 35880048)
1. Sex-biased adaptive immune regulation in cancer development and therapy. Schafer JM; Xiao T; Kwon H; Collier K; Chang Y; Abdel-Hafiz H; Bolyard C; Chung D; Yang Y; Sundi D; Ma Q; Theodorescu D; Li X; Li Z iScience; 2022 Aug; 25(8):104717. PubMed ID: 35880048 [TBL] [Abstract][Full Text] [Related]
2. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs. J Vis Exp; 2023 May; (195):. PubMed ID: 37235796 [TBL] [Abstract][Full Text] [Related]
3. Androgen conspires with the CD8 Kwon H; Schafer JM; Song NJ; Kaneko S; Li A; Xiao T; Ma A; Allen C; Das K; Zhou L; Riesenberg B; Chang Y; Weltge P; Velegraki M; Oh DY; Fong L; Ma Q; Sundi D; Chung D; Li X; Li Z Sci Immunol; 2022 Jul; 7(73):eabq2630. PubMed ID: 35420889 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptor-mediated CD8 Yang C; Jin J; Yang Y; Sun H; Wu L; Shen M; Hong X; Li W; Lu L; Cao D; Wang X; Sun J; Ye Y; Su B; Deng L Immunity; 2022 Jul; 55(7):1268-1283.e9. PubMed ID: 35700739 [TBL] [Abstract][Full Text] [Related]
5. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor. Zhao J; Wang Q; Tan AF; Loh CJL; Toh HC Front Immunol; 2024; 15():1416941. PubMed ID: 38863718 [TBL] [Abstract][Full Text] [Related]
7. Sex Hormones and Anticancer Immunity. Özdemir BC; Dotto GP Clin Cancer Res; 2019 Aug; 25(15):4603-4610. PubMed ID: 30890551 [TBL] [Abstract][Full Text] [Related]
8. Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications. Xiao T; Lee J; Gauntner TD; Velegraki M; Lathia JD; Li Z Nat Rev Cancer; 2024 May; 24(5):338-355. PubMed ID: 38589557 [TBL] [Abstract][Full Text] [Related]
10. Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer. Ben-Batalla I; Vargas-Delgado ME; von Amsberg G; Janning M; Loges S Front Immunol; 2020; 11():1184. PubMed ID: 32714315 [TBL] [Abstract][Full Text] [Related]
11. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. Li Z; Song W; Rubinstein M; Liu D J Hematol Oncol; 2018 Dec; 11(1):142. PubMed ID: 30577797 [TBL] [Abstract][Full Text] [Related]
12. Reinvigorating exhausted CD8 Hossain MA; Liu G; Dai B; Si Y; Yang Q; Wazir J; Birnbaumer L; Yang Y Med Res Rev; 2021 Jan; 41(1):156-201. PubMed ID: 32844499 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8 Ning K; Peng Y; Jiang Y; Li Z; Luo X; Lin L; Deng M; Wu Y; Huang T; Huang Y; Xie Y; Yang X; Zhang M; Xiong L; Zou X; Zhou Z; Zhou F; Dong P; Yu C; Zhang Z Biol Sex Differ; 2023 Sep; 14(1):58. PubMed ID: 37715192 [TBL] [Abstract][Full Text] [Related]
14. Oncolytic adenovirus decreases the proportion of TIM-3 Liikanen I; Basnet S; Quixabeira DCA; Taipale K; Hemminki O; Oksanen M; Kankainen M; Juhila J; Kanerva A; Joensuu T; Tähtinen S; Hemminki A J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35193929 [TBL] [Abstract][Full Text] [Related]
15. Connecting the mechanisms of tumor sex differences with cancer therapy. Li H; Jiang W; Liu S; Yang M; Chen S; Pan Y; Cui M Mol Cell Biochem; 2024 Feb; 479(2):213-231. PubMed ID: 37027097 [TBL] [Abstract][Full Text] [Related]
16. Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy. Zhou L; Velegraki M; Wang Y; Mandula JK; Chang Y; Liu W; Song NJ; Kwon H; Xiao T; Bolyard C; Hong F; Xin G; Ma Q; Rubinstein MP; Wen H; Li Z J Clin Invest; 2024 May; 134(14):. PubMed ID: 38787791 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment. Ma F; Vayalil J; Lee G; Wang Y; Peng G J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642246 [TBL] [Abstract][Full Text] [Related]
19. Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8 Li A; Chang Y; Song NJ; Wu X; Chung D; Riesenberg BP; Velegraki M; Giuliani GD; Das K; Okimoto T; Kwon H; Chakravarthy KB; Bolyard C; Wang Y; He K; Gatti-Mays M; Das J; Yang Y; Gewirth DT; Ma Q; Carbone D; Li Z J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096533 [TBL] [Abstract][Full Text] [Related]
20. Targeting the epigenome to reinvigorate T cells for cancer immunotherapy. Xiong D; Zhang L; Sun ZJ Mil Med Res; 2023 Dec; 10(1):59. PubMed ID: 38044445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]